Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coherus BioSciences Inc.

www.coherus.com

Latest From Coherus BioSciences Inc.

Keeping Track: Seqirus Pandemic Flu Vaccine Approved; Trevena Resubmits Oliceridine

The latest drug development news and highlights from our US FDA Performance Tracker.

US FDA Performance Tracker Drug Review

Formycon Delay Pushes Back Coherus’ Ranibizumab

Formycon and Bioeq’s US filing for a biosimilar ranibizumab rival to Lucentis has been delayed after the FDA requested further data following a manufacturing change. Rights to the biosimilar have been licensed exclusively to Coherus in the US.

Biosimilars Regulation

Biosimilars: A Decade In Review

The past decade has been transformative for the global biosimilars industry as regulators, developers, physicians, patients and payers from all over the world have grappled with complex, and often market-shaping, issues.

Biosimilars Regulation

Who’s Hired? Sandoz Germany Seeks A New Country Head

While Sandoz looks for a new country head in Germany, Lupin has appointed a new chief corporate development officer and a Coherus executive has left the firm.

Appointments Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Dermatology
  • Gastrointestinal
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Ophthalmic
  • Alias(es)
  • BioGenerics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Coherus BioSciences Inc.
  • Senior Management
  • Dennis Lanfear, Chmn., Pres. & CEO
    Jean-Frederic Viret, PhD, CFO
    Vladimir Vexler, PhD, CSO
    Barbara K Finck, MD, Acting CMO
    Vince Anicetti, COO
    Erik Wiberg, EVP, Corp. Dev.
  • Contact Info
  • Coherus BioSciences Inc.
    Phone: (800) 794-5434
    333 Twin Dolphin Dr., Ste. 600
    Redwood City, CA 94065
    USA
UsernamePublicRestriction

Register